Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Goodwin Procter LLP ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Risk Adjustment & Assessment In The Payor Universe (Video Content)
Closing the Healthcare Growth Cap Conference on April 11th, 2013, Stuart Rosenthal, Partner in the Business Law Department at Goodwin Procter moderates a panel that addresses three critical themes.
United States
22 Jul 2013
2
Alternative Financing Strategies For Growth Stage Healthcare Companies (Video Content)
Moderating the Alternative Financing Strategies for Growth Stage Healthcare Companies panel discussion at the Healthcare Growth Cap Conference on April 11, 2013.
United States
10 Jun 2013
3
HHS Issues Long-Awaited Final HIPAA Omnibus Rule
On January 17, 2013, the Office for Civil Rights ("OCR") of the U.S. Department of Health and Human Services ("HHS") released its much-anticipated final HIPAA omnibus rule.
United States
6 Feb 2013
4
When Complying With HIPAA Is Not Enough: Tough New Medical Privacy Laws Are In Effect In Texas
While many covered entities and business associates are still adjusting to the changes to the Health Insurance Portability and Accountability Act ("HIPAA") ushered in by the Health Information Technology for Economic and Clinical Health Act, new privacy requirements that are more stringent than HIPAA recently entered into force in Texas.
United States
8 May 2012
5
Implementation Of The Biologics Price Competition And Innovation Act
A statutory and regulatory scheme to encourage the development of "biologics," drug products made in living organisms, has been a goal for more than a decade, and the Biologics Price Competition and Innovation Act ("BPCIA") was enacted on March 23, 2010.
United States
8 May 2012
6
Lessons From Mayo v. Prometheus: Assessing Patentability And Obtaining Patent Protection For "Laws Of Nature" Inventions
It is well established that "laws of nature, natural phenomena, and abstract ideas," themselves, are not patentable subject matter under §101 of the Patent Act, while an application of a law of nature, phenomena or abstract idea may be patentable.
United States
 
30 Mar 2012
7
Supreme Court Expands "Laws Of Nature" Exception To Patentability In Mayo V. Prometheus
This week, the U.S. Supreme Court reshaped the landscape of patent law with its long-awaited decision in Mayo Collaborative Services v. Prometheus Laboratories.
United States
 
30 Mar 2012
8
Landmark Healthcare Reform Legislation Creates Statutory Pathway For Biosimilar Biologics
On March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act of 2010 ("PPACA"), Public Law No. 111-148.
United States
13 Apr 2011
9
Early Retiree Reinsurance Program Becomes Effective June 1, 2010
The Department of Health and Human Services ("HHS") has issued interim final rules relating to the Early Retiree Reinsurance Program introduced by the Health Care Reform Acts.
United States
19 May 2010
10
Health Care Reform Mandates Extended Coverage for Children Until Age 26 and Exempts from Taxation Medical Benefits for Children up to Age 27
The recently enacted Patient Protection and Affordable Care Act, as amended by the 2010 Health Care Reconciliation Act (together, the "Health Care Reform Acts"), imposes a new requirement on group health plans that provide for coverage of dependents of a covered individual.
United States
12 May 2010
11
Landmark Healthcare Reform Legislation Creates Statutory Pathway for Biosimilar Biologics
On March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act of 2010 ("PPACA"), Public Law No. 111-148. This massive, groundbreaking piece of legislation contains, or the first time, a statutory pathway for licensure, or approval, of biological products that are biosimilar to, and possibly interchangeable with, earlier biological products (termed "reference products") licensed under the Public Health Service Act.
United States
7 Apr 2010
12
New Law Establishes Tax Credits for Qualifying Therapeutic Discovery Projects
The Patient Protection and Affordable Care Act, signed into law by President Obama on March 23, 2010, establishes a new tax credit that may be of significant benefit to small and mid-sized life sciences companies.
United States
2 Apr 2010
13
FTC Weighs In As Congress Considers Generic Biologics
This year marks the 25th anniversary of the Hatch-Waxman Act in the United States, which created a pathway for generic drugs by means of an abbreviated version of a New Drug Application for small molecule drugs regulated by the Federal Food, Drug, and Cosmetic Act.
United States
19 Jun 2009
14
FDA Takes Action In Response To Swine Flu Threat
In response to requests from the U.S. Centers for Disease Control and Prevention (“CDC”), FDA has issued emergency use authorizations (“EUAs”) to make important diagnostic and therapeutic tools available to the public.
United States
12 Jun 2009
15
Children’s Health Insurance Program Reauthorization Act Imposes New Group Health Plan Enrollment Rights And Obligations On Employers
President Obama signed the Children’s Health Insurance Program Reauthorization Act of 2009 into law on February 4, 2009 (the “Act”).
United States
31 Mar 2009
16
Massachusetts Issues Final “Gift Ban” Regulation Regarding Pharmaceutical And Medical Device Manufacturer Conduct
Massachusetts has issued a final regulation implementing a sweeping new regime affecting the way biotechnology, pharmaceutical and medical device companies can market their products within the Commonwealth.
United States
25 Mar 2009
17
Economic Stimulus Legislation Expands Scope And Enforcement Of HIPAA
On February 17, 2009, in response to concerns over continually weakening economic conditions, President Obama signed into law the American Recovery and Reinvestment Act of 2009 (“ARRA”).
United States
 
16 Mar 2009
18
Temporary COBRA Subsidy Included In The American Recovery And Reinvestment Act Of 2009
The American Recovery and Reinvestment Act of 2009 was signed into law by President Obama on February 17, 2009.
United States
23 Feb 2009
19
Massachusetts Life Sciences Center Launches New Tax Incentive And Early-Stage Investment Programs
The Massachusetts Life Sciences Center (the “MLSC”), a quasi-public agency tasked with implementing the State’s $1 billion Life Sciences Initiative, is now accepting online applications for its Life Sciences Tax Incentive Program and its Life Sciences Accelerator Program.
United States
2 Feb 2009
20
EPA Takes First-Ever Regulatory Actions Aimed At Potential Nanomaterial Risks
The U.S. Environmental Protection Agency (“EPA”) has taken its first clear steps to directly regulate the potential environmental, health and safety (“EHS”) risks associated with the manufacture and use of nanomaterials.
United States
10 Nov 2008
Links to Result pages
 
1 2  
>>Next